Navigation Links
Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
Date:5/29/2009

leukemic blasts in bone marrow or peripheral blood (10 percent), in patients with known hypersensitivity to GM-CSF, yeast derived products or any component of Leukine, and for concomitant use with chemotherapy and radiotherapy. Serious allergic or anaphylactic reactions have been reported with Leukine. If any serious or anaphylactic reactions occur, Leukine therapy should immediately be discontinued and appropriate therapy initiated. Leukine should be used with caution and monitored in patients with preexisting fluid retention, pulmonary infiltrates or CHF; respiratory symptoms or disease; cardiac symptoms or disease; and renal or hepatic dysfunction. Edema, capillary leak syndrome, pleural and or/pericardial effusion, supraventricular tachycardia, sequestration of granulocytes in the pulmonary circulation and dyspnea have been reported in patients after Leukine administration. Leukine has induced the elevation of serum creatinine or bilirubin and hepatic enzymes in some patients. Monitoring of renal and hepatic function in patients with preexisting renal or hepatic dysfunction is recommended at least every other week during Leukine administration. Adverse events occurring in 10 percent of AML patients receiving Leukine in controlled clinical trials and reported in a higher frequency than placebo were: fever, skin reactions, metabolic disturbances, nausea, vomiting, weight-loss, edema, and anorexia. If ANC 20,000 cells/mm3 or if platelet counts 500,000 mm3, Leukine administration should be interrupted or the dose reduced by half. Twice weekly monitoring of CBC with differential should be performed. Leukine therapy should be discontinued if disease progression is detected during treatment.

For more information about Leukine, including full prescribing information, visit www.leukine.com.

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceutica
'/>"/>

SOURCE Bayer Healthcare Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... , October 31, 2014 Multigate ... Australian patents of B. Braun Melsungen AG (B. Braun) by ... safety IV catheters manufactured by Poly Medicure Ltd (Polymed). ... Australia proceeding number VID 463 of 2013 can ... the detailed judgment, Multigate was found to have infringed claim ...
(Date:10/31/2014)... 30, 2014 ... addition of the  "Process Validation in the US ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,Key topics ... Based Approach to Process Validation for Pharmaceutical and ... FDA Process Validation Guidance EU ...
(Date:10/31/2014)... Oct. 31, 2014 Though therapies are in ... expected to show an annual increase of 16.2% over ... nearly $1 billion, according to Kalorama Information,s report, ... stem cell therapeutics that have gained or are expected ... "As drug developers tackle ever more complicated conditions, stem ...
Breaking Medicine Technology:B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2Process Validation in the US and EU (Workshop, London) 2Process Validation in the US and EU (Workshop, London) 3Process Validation in the US and EU (Workshop, London) 4Report: Stem Cell Technologies Market Growing 2
(Date:10/31/2014)... – New research suggests that insomnia is a major ... other unintentional fatal injuries. The results underscore the importance ... National Healthy Sleep Awareness Project. , Results show that ... dose-dependent manner with the number of insomnia symptoms present. ... times more likely to die from a fatal injury ...
(Date:10/31/2014)... Denver, Colorado (PRWEB) October 31, 2014 ... reveals that this workout program was developed by Dan ... also become well-known as a fitness professional and life ... stubborn fat and having toned muscles is not impossible ... in based on suspension training. Suspension training promises efficiency ...
(Date:10/31/2014)... October 31, 2014 Florida Air ... and girls in grades 6-12, is taking the ... sports injuries and concussions, becoming the first high ... ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing) computerized ... NFL Player' lawsuit grabs the headlines, and the ...
(Date:10/31/2014)... Phoenix dentist , Dr. Christy, is now offering ... simply need routine care or have a more in-depth dental ... get that necessary care. The right dental treatments can transform ... essential treatments due to financial concerns. Throughout the month of ... offered by the team at Christy Dental Care. , ...
(Date:10/31/2014)... Boca Raton, FL (PRWEB) October 31, 2014 ... wellness company founded on the highest principles of patient ... Lifescript , a leading health and wellness website, to ... those living with diabetes. , The Diabetes Health ... tips and recipes for those living with diabetes. Content ...
Breaking Medicine News(10 mins):Health News:Insomnia increases risk of motor vehicle deaths, other fatal injuries 2Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3Health News:Phoenix Dentist, Dr. Christy, is Now Offering Ten Percent Off On All Dental Treatments for the Month of November 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 3
... are known to be good for lowering cholesterol and ... reported benefit: they appear to slow decline in lung ... According to researchers in Boston, it may be statins ... , Their findings were published in the second issue ...
... hire an ad agency; at,least not initially especially if you ... an agency can,t come up with something great. It,s,just that ... Most clients follow tradition process in attempting to find ... develop a,short list of 3 agencies and ask for a ...
... Educate Chicagoans, CHICAGO, Oct. 11 Continuing ... of Chicago, SAVE THE PATIENT, a,not-for-profit patient-focused organization, ... Chicago Access Network. "Community Health Hotline" will,air Monday, ... 21., Monday,s program will feature a frank ...
... /Xinhua-PRNewswire/ -- On,October 10, 2007, Synutra International, Inc. ... dairy-based nutritional products,for infants, children and adults, received ... the Company,s common stock is no longer subject ... October 5, 2007 of the,Company,s quarterly report on ...
... Monday will be a little,cooler for the patients ... the entire Washington Capitals team will make their annual,visit. ... raise money for,cancer research, Courage Caps., Courage Caps ... the season at Capitals home games and online at ...
... who overcome breast cancer have every reason to celebrate. ... a heart damaged by life-saving cancer therapies, a growing ... today including new treatments still under development ... Jones, Ph.D., an exercise physiologist and assistant professor in ...
Cached Medicine News:Health News:Statins reduce loss of function, keeping old lungs young - even in smokers 2Health News:A New Way to Discover Marketing Ideas 2Health News:Patient Empowerment -- Medication Error 2Health News:Nasdaq Informs Synutra that the Company's Filing Delinquency has been Cured 2Health News:Breast cancer awareness calls for cardiovascular awareness 2Health News:Breast cancer awareness calls for cardiovascular awareness 3
A budget-priced microscope designed for ENT and neuro surgery....
... has pioneered the development of ... system, an innovative solution that ... efficient and less invasive. The ... the OME-7000 surgical microscope, the ...
... Leica M501 TTS offers the comfort of ... and training application. The microscope offers brilliant ... stereopsis and natural color reproduction. A separate ... can be optimized with a special jalousie ...
The Leica M500 OH3 is an advanced surgical microscope used by neurosurgeons. It is a smart system combining the best optical performance available on the market with an innovative and unique stand....
Medicine Products: